Introduction
Aneurysmal subarachnoid hemorrhage (aSAH) remains a devastating disease despite recent advances in its treatment 1 4 . Several population-based studies have reported Association/American Stroke Association guidelines 9 recommend the evaluation of patients with aSAH according to the grading system, these guidelines provide no clear recommendation for poor-grade aSAH treatments. Although the aSAH gradings may predict outcome, they are based simply on the initial neurological assessment of the patient on admission 5 7 . Moreover, the data of their original studies were accumulated approximately half a century ago 5 7 .
The last 5 decades have witnessed progress in diagnostic imaging (e.g., computed tomography [CT] and CTangiography) and treatments (e.g., clipping, coiling, and perioperative neurocritical care), which have resulted in better patient outcomes after aSAH, including in poorgrade cases 10 12 . Although several CT classifications, such as the Fisher 13 , modified Fisher 14 , Classen 15 , Hijdra 16 , and
Barrow Neurological Institute scales 17 have been developed, these are scales predicting vasospasm and do not provide helpful information for decision making or predict long-term functional outcome after SAH. Thus, new CT classifications providing information that can assist the choice for the proper treatment strategy for poorgrade SAH are required. Regarding novel treatments, "ultra-early" surgeries to avoid re-bleeding were proposed with potentially promising results 18, 19 . Because approximately 50% of re-bleeding occurs within 6 hours after ictus 20 , ultra-early treatment may be a reasonable strategy to prevent re-bleeding with the worst outcome.
However, robust evidence for this treatment is still lacking.
We therefore hypothesized that there may be some subgroups of patients who have a greater survival potential when treated with ultra-early surgeries among poorgrade aSAH. The aim of the current study was to evaluate the outcome of ultra-early treatment for patients with poor-grade aSAH who were sub-classified based on their initial CT results.
Materials and Methods
This retrospective clinical study included patients from the Department of Emergency and Critical Care Medicine, Nippon Medical School, Tama Nagayama Hospital, a tertiary care emergency medical and trauma center in the western part of Tokyo, Japan. Our institutional review boards approved this study (No. 2018-556) .
Definitions and Treatment Protocols
In principle, we provide definitive treatment and perioperative neurocritical care to all patients with aSAH, including poor-grades cases, as per our institutional protocol. In the current study, patients with aSAH were excluded from definitive treatment if they had cardiopulmonary arrest upon arrival (CPAOA) 21, 22 or no brainstem reflexes after their initial management 21, 22 . In order to avoid re-bleeding, the provision of ultra-early surgery is a primary strategy in our institution. We defined ultraearly surgery as that initiated within 6 hours following arrival at the emergency department.
As soon as a patient with suspected aSAH was brought to our emergency department, we provided general anesthesia for them following an evaluation of their neurological status and initial basic management. General anesthesia involved rapid induction and total intravenous anesthesia for maintenance. Strict blood pressure (systolic blood pressure less than 120 mmHg) control was also performed 23, 24 . CT and CT-angiography were performed in order to arrive at a definite diagnosis and to detect the bleeding site 25, 26 . Digital subtraction angiography (DSA) was added for patients whose CTangiography failed to detect an aneurysm 27, 28 , for the detection of perforating artery branches from the aneurysmal neck, and for confirming the venous system when it
was necessary for open surgery. We did not wait for recovery of consciousness in patients with aSAH and provided treatment for ruptured aneurysms regardless of the aSAH grade because poor-grade aSAH is one of the important predictors of re-bleeding, which most often occurs within a few hours of the first ictus 29, 30 .
According to the CT findings, patients with aSAH were divided into the following 3 groups ( Fig. 1 35 37 .
We set a goal to start treatment for the ruptured aneurysms within 6 hours of admission (i.e., ultra-early treatment). For Group 1 and 3 patients, the treatment of choice for the ruptured aneurysms (i.e., surgical clipping or coil embolization) was selected based on the site, size, and shape of the aneurysm. For patients who were comparably suited to either treatment modality, endovascular coiling was selected 38, 39 . The optimal treatment modality was decided through discussion among all doctors in charge at our department. 
Endpoints
The primary outcomes for the current study were functional outcome and all-cause mortality at 6 months. The functional outcome was assessed based on the modified Rankin Scale (mRS) data collected on outpatient basis or via telephone questionnaires conducted by 2 independent neurosurgeons at our institution. Scores were classified as good (mRS scores 0 to 2) or poor functional outcomes (mRS scores 3 to 6) 46 .
Statistical Analysis
We compared the background characteristics and treatments between the good and poor functional outcome groups. Continuous variables were compared between the groups using a t-test or Mann-Whitney's U test and categorical variables were analyzed using chi-square or
Fisher's exact tests, as appropriate. We further performed a stratified analysis according to the results of the initial CT. We performed a logistic regression analysis in which CT classification was associated with the primary outcome, and adjusted for the following factors: age, sex, treatment methods, and time from onset to definitive treatment. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. All data were analyzed using SPSS 23.0 for Windows (IBM Corp., Armonk, NY, USA); p < 0.05 was considered statistically significant.
Results

Patient Selection and Baseline Characteristics
During the study period, a total of 3,625 patients were admitted to our department; one quarter of whom were admitted due to stroke. A total of 157 patients with aSAH were admitted to our hospital. We excluded 25
CPAOA cases that were diagnosed by lumbar puncture or autopsy imaging. Among the 132 remaining patients with aSAH, 85 were patients with a poor-grade (64.4%).
Eight of those patients had no brainstem reflex after ICP management (respiratory management, mannitol infusion, and EVD) and supportive care was commenced without providing a definitive treatment. Two patients were transferred from another hospital after initial management and 4 patients were lost to follow up. In total, 71 patients, 23 with WFNS grade IV and 48 with grade V, were included in the current study (Fig. 2) . Table 1 presents the baseline characteristics of the study patients.
Average time from admission to emergent EVD insertion and emergent surgery in Group 2 was 105 and 127 minutes, respectively.
Outcomes
A good functional outcome (mRS scores of 0 to 2) was observed in 39.4% (28/71) of patients Table 2 . We found that 47.9% (34/71) of patients had an mRS score of 3 or less (i.e., mRS scores of 0 to 3). All-cause mortality at 6 months was 15.5% (11/71). There was a significantly higher number of patients with good outcomes in Group 3 than in the other 2 groups (Group 1 and 2 vs. Group 3, In this study, re-bleeding before definitive treatment occurred in 5 cases (7.0%) Table 3 . In 2 of 5 cases, rebleeding occurred throughout the induction of general anesthesia. In the remaining 3 cases, re-bleeding occurred while the patients were waiting for their operations and all cases were due to a dissecting aneurysm (a dissection of posterior inferior cerebellar artery, an internal carotid All data were presented with n (%) artery anterior wall blister-like aneurysm and a dissec- 
Discussion
In the current study, we found that 39.4% of patients with aSAH with WFNS grades VI or V experienced good functional outcomes (mRS scores of 0 to 2) 6 months after receiving ultra-early surgery and subsequent neurocritical care. All-cause mortality at 6 months was 15.5% among these patients. Importantly, approximately half of the patients with poor-grade aSAH without CTconfirmed IVH-hydro or ICH-herni experienced good functional outcomes at 6 months.
In the latest European Stroke Organization guidelines 8 and American Heart Association/American Stroke Association guidelines 9 , although use of the grading systems is recommended for the prediction of outcome, there are no guidelines indicating whether treatment should vary according to grade. In the current study, we provided ultra-early treatment with perioperative neurocritical care to all patients with aSAH (except for patients after CPAOA or with no brainstem reflex), including poorgrades cases, as per our institutional protocol. Although most studies define early treatment as initiating treatment within 72 hours, we aimed to initiate definitive treatment within 6 hours. In our study, the re-bleeding rate of ruptured aneurysms was much lower (7.0%) than that reported in previous studies 19 .
In the original papers by Hunt, which were published in 1968 5 and in 1974 6 , patients with grade III or worse
were not treated in the early stage, resulting in mortality rates of 100% for patients with grade V and 93% for grade IV, respectively. Moreover, in a large international study that was used for WFNS grading 47 , two thirds of comatose patients did not receive any definitive treatment for ruptured aneurysms, which resulted in a good outcome in only 13% of patients. One of the reasons for this catastrophic finding may be due to re-bleeding in the early phases after SAH. The risk of re-bleeding is highest in the acute phase, with a re-bleeding rate of approximately 9-17% within the first 24 hours 48 . Nearly 30% of all re-bleeding occurs within 3 hours, and nearly 50% occurs within 6 hours of symptom onset 20 . Early re-bleeding is associated with worse outcomes 20 . Patients with poorgrade tend to be at a higher risk of re-bleeding 19, 49 . Ideally, aneurysm obliteration should be performed as early as possible to prevent re-bleeding 8, 9 . However, the benefits of early definitive treatment remain controversial for patients with aSAH 50 , especially for those with poorgrade aSAH. One study showed early definitive treatment to be associated with less re-bleeding and a higher proportion of favorable outcomes 18 , while another did not 51 .
Regarding severity, the functional outcome of patients with grade IV was better than that of patients with grade V. GCS on admission was also significantly related to functional outcome. However, there was no significant difference in functional outcome for patients with GCS 3 compared with patients with GCS 4 to 6. Of all treated patients, one recent report concerning only patients with grade V suggested that there was no difference in functional outcome between the GCS 3 and GCS 4 to 6 subgroups 52 . There is a possibility that GCS 3 is not necessarily the severest in terms of functional outcome among patients with grade V who undergo definitive treatment.
Originally, conventional CT sub-classifications were established for the prediction of vasospasm 13 17 . Although DCI due to vasospasm is one of the main causes of poor outcome, it is not the only one. Despite the higher rate of vasospasm in patients with a poor-grade 14, 53 , our results
show that severe vasospasm and DCI due to severe vasospasm occurred in only 7% and 4.2% of patients, respectively. In addition, almost all patients with a poor-grade are ordinarily categorized in a limited group, such as Fisher group 3 or 4, because of the large volume of the hemorrhage. In the current study, we used a standardized approach for patients with a poor-grade where we used the CT results to categorize the treatment plan and considered both ICP and definitive aneurysmal treatment. For patients in Group 1 in our protocol, i.e., those with IVH-hydro, the immediate insertion of EVD to control ICP was essential for life-saving purposes 33, 34 . There were some limitations to the current study. First, this was a single center observational study performed at a tertiary care emergency hospital in Japan without a control group. Therefore, we cannot generalize the results of the current study to other institutions or different emergency system areas. Second, although we evaluated the 6-month functional outcome in the current study, longer follow-up periods (e.g., 1 year or more) may be preferable for the evaluation of long-term functional outcomes. However, we selected a 6-month follow-up period because of its feasibility in the current study, which fo- 
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